Literature DB >> 92764

Ionomycin stimulates mast cell histamine secretion by forming a lipid-soluble calcium complex.

J P Bennett, S Cockcroft, B D Gomperts.   

Abstract

The activation of cellular function following the direct introduction of Ca2+ into the cytosol by the use of a Ca2+-transporting ionophore has served to confirm the widely held idea that Ca2+ has the status of a second messenger in many cell types. However, this evidence has been obtained largely from the use of a single ionophore, the antibiotic A23187; experiments with X537A, which is another ionophorous antibiotic capable of transporting Ca2+ (ref. 3), have failed to show the expected characteristics. For example, histamine release from rat mast cells mediated by X537A is neither dependent on extracellular Ca2+ nor prevented by metabolic inhibitors. Ionomycin is a recently described polyether antibiotic produced by Streptomyces conglobatus ATCC 31005, and is active against Gram-positive bacteria. The antibiotic action is presumably due to its ionophorous properties, as it extracts Ca2+ from an aqueous phase into an organic phase with a stoichiometry of 1:1 (ref. 6). The ionophore is also capable of transporting 45Ca2+ across biological membranes (our unpublished results). Here we report the application of ionomycin to rat mast cells. We show that ionomycin stimulates mast cell secretion solely through its ability to form a lipid-soluble calcium complex, and thus to convey Ca2+ across the hydrocarbon region of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92764     DOI: 10.1038/282851a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Effects of the divalent cation ionophore ionomycin on the performance of isolated guinea-pig atria.

Authors:  H M Himmel; R Riehle; K Stieler; M Siess
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

2.  Regulation of exocytosis from rat peritoneal mast cells by G protein beta gamma-subunits.

Authors:  J A Pinxteren; A J O'Sullivan; P E Tatham; B D Gomperts
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

3.  Deliberate quin2 overload as a method for in situ characterization of active calcium extrusion systems and cytoplasmic calcium binding: application to the human platelet.

Authors:  J S Johansson; D H Haynes
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

4.  Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells.

Authors:  Ihab T Abdel-Raheem; Izumi Hide; Yuhki Yanase; Yukari Shigemoto-Mogami; Norio Sakai; Yasuhito Shirai; Naoaki Saito; Farid M Hamada; Nagh A El-Mahdy; Alaa El-Din E Elsisy; Samya S Sokar; Yoshihiro Nakata
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  c-kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling.

Authors:  K Vosseller; G Stella; N S Yee; P Besmer
Journal:  Mol Biol Cell       Date:  1997-05       Impact factor: 4.138

6.  The ATP4- receptor of rat mast cells.

Authors:  S Cockcroft; B D Gomperts
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

7.  Comparative effects of oxatomide on the release of histamine from rat peritoneal mast cells.

Authors:  F De Clerck; J Van Reempts; M Borgers
Journal:  Agents Actions       Date:  1981-05

8.  Rat mast cells permeabilized with ATP secrete histamine in response to calcium ions buffered in the micromolar range.

Authors:  J P Bennett; S Cockcroft; B D Gomperts
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

9.  Histamine release from human pulmonary mast cells.

Authors:  M Ennis
Journal:  Agents Actions       Date:  1982-04

10.  Membrane potential changes during IgE-mediated histamine release from rat basophilic leukemia cells.

Authors:  R Sagi-Eisenberg; I Pecht
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.